Results per Page:

Travel writer takes an unexpected cancer journey
Writer and TV host Rick Steves deals with a prostate cancer diagnosis and offers hope to others

Polygenic risk scores and prostate cancer
New research shows genetic risk scores could help distinguish who can cut back on ‘active surveillance’

BRCA1/2: Why men should be screened for the “breast cancer gene”
New research shows that men can carry mutations in the BRCA1 and BRCA2 genes that increase their risk of several cancers, but new national guidelines are helping to educate patients

Active surveillance shown to be an effective management strategy for prostate cancer patients
Study evaluated long-term outcomes of using active surveillance instead of immediate treatment with surgery or radiation

ASCO 2023 highlights: Fine-tuning cancer care
Annual oncology meeting emphasizes less-toxic treatments, more precision oncology and new ways to reduce collateral damage

African Americans and the risk of reclassification in Active Surveillance
From the Lin Group, Division of Public Health Sciences

Black men with early-stage prostate cancer can do active surveillance
New study using Canary PASS data shows African American men with low-risk disease can delay radical treatment just like white men

Fred Hutch receives 5 years of NCI funding to grow and maintain key prostate cancer cohort
$6.7M grant will boost size, participant diversity of Canary Prostate Active Surveillance Study

The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment

What’s new in prostate cancer? 5 things to watch
Highlights from the Institute for Prostate Cancer Research 2017 community symposium

6 things men need to know about prostate cancer
Experts share their insight on screening, treatment, clinical trials and more

Advanced prostate cancer and the age factor
Seattle Cancer Care Alliance physicians design University of Washington-based study to examine association between age at prostate-cancer diagnosis and health outcomes